Personalised Medicine Market and Regulatory Landscape
Posted in Archive
| Tagged Academic, Analysis, Assay development optimisation & technology, Biomarkers, Business, Drug development, Drug discovery, Genetics / genomes, Genomics, High throughput screening, Imaging, Lead discovery, Molecular medicine, Oncology, Pharmacogenomics, Preclinical, Protein chemistry / Proteomics, Regulatory, RNA, Target validation, Therapeutics, Toxicology
